Vimarsana
Biggest News Aggregation in the World

Page 4 - Polypeptide Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Polypeptide Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Polypeptide Group Today - Breaking & Trending Today

Torrance biotech company settles with EPA over not complying with hazardous waste law - Vimarsana News

Torrance biotech company settles with EPA over not complying with hazardous waste law

Polypeptide Labs Inc. has agreed to pay $57,472 for violating the Resource Conservation and Recovery Act.

PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 - adhoc - Börsennachrichten - Vimarsana News

PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 - adhoc - Börsennachrichten

PolyPeptide Group Key word Profit Warning PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 13Jul2023 0700 CETCEST Release of an ad hoc announ

PolyPeptide Group AG's (VTX:PPGN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Vimarsana News

PolyPeptide Group AG's (VTX:PPGN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

PolyPeptide Group's (VTX:PPGN) stock is up by a considerable 18% over the past three months. But the company's key...

Source: yahoo.com
Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group - Vimarsana News

Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group

Lund, June 12, Hamlet Pharma, ticker HAMLET, soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces that Hamlet Pharma has extended and expanded the agreement with the Swiss public company Polypeptide Group, ticker PPGN, to produce larger quantities of the synthetic peptide Alpha1. The new production, at a larger scale, will be essential for future expansions of the clinical trial program in bladder cancer.

Source: di.se
Global Peptide Therapeutics Market Report 2023: Sector is - Vimarsana News

Global Peptide Therapeutics Market Report 2023: Sector is

Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region -...